These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 26681753)

  • 1. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
    Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr
    Kareinen I; Baumann M; Nguyen SD; Maaninka K; Anisimov A; Tozuka M; Jauhiainen M; Lee-Rueckert M; Kovanen PT
    J Lipid Res; 2018 Jun; 59(6):945-957. PubMed ID: 29581158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase. Implications for HDL function.
    Lee M; Uboldi P; Giudice D; Catapano AL; Kovanen PT
    J Lipid Res; 2000 Jun; 41(6):975-84. PubMed ID: 10828090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
    Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of chymase-digested C-terminally truncated apolipoprotein A-I in normal human serum.
    Usami Y; Matsuda K; Sugano M; Ishimine N; Kurihara Y; Sumida T; Yamauchi K; Tozuka M
    J Immunol Methods; 2011 Jun; 369(1-2):51-8. PubMed ID: 21497162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human apolipoprotein A-I exerts a prophylactic effect on high-fat diet-induced atherosclerosis via inflammation inhibition in a rabbit model.
    Li J; Wang W; Han L; Feng M; Lu H; Yang L; Hu X; Shi S; Jiang S; Wang Q; Ye L
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):149-158. PubMed ID: 28069582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity.
    Dinnes DL; White MY; Kockx M; Traini M; Hsieh V; Kim MJ; Hou L; Jessup W; Rye KA; Thaysen-Andersen M; Cordwell SJ; Kritharides L
    FASEB J; 2016 Dec; 30(12):4239-4255. PubMed ID: 27630170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins.
    Di Bartolo BA; Nicholls SJ; Bao S; Rye KA; Heather AK; Barter PJ; Bursill C
    Atherosclerosis; 2011 Aug; 217(2):395-400. PubMed ID: 21571275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant lectin-like domain of thrombomodulin suppresses vascular inflammation by reducing leukocyte recruitment via interacting with Lewis Y on endothelial cells.
    Lin WL; Chang CF; Shi CS; Shi GY; Wu HL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2366-73. PubMed ID: 23950139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma.
    Lee M; von Eckardstein A; Lindstedt L; Assmann G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1066-74. PubMed ID: 10195937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell chymase induces smooth muscle cell apoptosis by disrupting NF-kappaB-mediated survival signaling.
    Leskinen MJ; Heikkilä HM; Speer MY; Hakala JK; Laine M; Kovanen PT; Lindstedt KA
    Exp Cell Res; 2006 May; 312(8):1289-98. PubMed ID: 16460729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages.
    Smythies LE; White CR; Maheshwari A; Palgunachari MN; Anantharamaiah GM; Chaddha M; Kurundkar AR; Datta G
    Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1538-48. PubMed ID: 20219948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neopterin Counters Vascular Inflammation and Atherosclerosis.
    Shirai R; Sato K; Yamashita T; Yamaguchi M; Okano T; Watanabe-Kominato K; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29420219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. META060 attenuates TNF-α-activated inflammation, endothelial-monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-κB and AP-1 in THP-1 monocytes.
    Desai A; Darland G; Bland JS; Tripp ML; Konda VR
    Atherosclerosis; 2012 Jul; 223(1):130-6. PubMed ID: 22658256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.
    Tabet F; Remaley AT; Segaliny AI; Millet J; Yan L; Nakhla S; Barter PJ; Rye KA; Lambert G
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):246-52. PubMed ID: 19965776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.
    Nobécourt E; Tabet F; Lambert G; Puranik R; Bao S; Yan L; Davies MJ; Brown BE; Jenkins AJ; Dusting GJ; Bonnet DJ; Curtiss LK; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):766-72. PubMed ID: 20110571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediators released from LPS-challenged lungs induce inflammatory responses in liver vascular endothelial cells and neutrophilic leukocytes.
    Markovic N; McCaig LA; Stephen J; Mizuguchi S; Veldhuizen RA; Lewis JF; Cepinskas G
    Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1066-76. PubMed ID: 19815624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse.
    Lee-Rueckert M; Silvennoinen R; Rotllan N; Judström I; Blanco-Vaca F; Metso J; Jauhiainen M; Kovanen PT; Escola-Gil JC
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):520-7. PubMed ID: 21212401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation.
    Roy A; Ganesh G; Sippola H; Bolin S; Sawesi O; Dagälv A; Schlenner SM; Feyerabend T; Rodewald HR; Kjellén L; Hellman L; Åbrink M
    J Biol Chem; 2014 Jan; 289(1):237-50. PubMed ID: 24257755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion.
    Usami Y; Kobayashi Y; Kameda T; Miyazaki A; Matsuda K; Sugano M; Kawasaki K; Kurihara Y; Kasama T; Tozuka M
    Biosci Rep; 2012 Dec; 33(1):49-56. PubMed ID: 23072735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.